Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
NYBA Annual Meeting: The Wrap Up
The New York Biotech Association Annual Meeting last Wednesday and Thursday was a success, showcasing 15 emerging companies as well as two dozen panels over the two-day span. Held in the Marriott Marquis Hotel, a staple of Times Square, the 21st annual conference was well attended.
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
Editor’s Note May 1, 2012
This week, OneMedPlace brings you a special report on CIN. In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report […]
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed?
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.
OneMedRadio Discusses Gene Therapy and Diagnostics with Dr. Andrew Senyei
OneMedRadio interviewed, Andrew Senyei, an MD with an interest in individualized DNA sequencing and gene therapy for heart disease.
Dr. Shi of EdgeTech Law: Genome Sequencing Could Soon Enter Mainstream
In Part III of our interview with Dr. Qin Shi of Edgetech Law we visit the concept of human genome sequencing as a mainstream commodity.
